The pituitary is an endocrine gland with ability to uptake diverse radiopharmaceuticals and,
therefore, susceptible to be investigated by nuclear medicine diagnostic procedures …

Scintigraphy with [111In-DTPA-D-Phe]-octreotide is a recently developed technique for
imaging somatostatin receptors in many neuroendocrine tumors. A good correlation …

To assess the role of scintigraphy with 111In-DTPA-D-Phe-octreotide (111In-octreotide) in
the diagnosis of pituitary adenomas and in the evaluation of post-surgical recurrent or …

The clinical significance of pituitary uptake on routine whole body 18 F-fluorodeoxyglucose
(FDG) positron emission tomography/computer tomography (PET/CT) is not completely …

Purpose The purpose of this study was to determine the incidence of incidental pituitary
uptake on whole-body 18 F-fluorodeoxyglucose (FDG) positron emission …

This is a case of a 48-year-old man treated with surgery and 131 I for papillary thyroid
carcinoma: a follow-up 18 F-FDG PET/CT incidentally evidenced pituitary uptake, also seen …

R. Ersoy, O. Topaloglu, C. Aydin, et al. rated gradually and died approximately 12 months
after the demonstration of hypophyseal tumor. FDG-PET is an established method in the …

Scintigraphy with 111 In-DTPA-octreotide (111 In-octreotide) enables the localization of
tumours with somatostatin receptors on their cell membranes, of which pituitary adenomas …

Abstract Objectives 68 Ga‐DOTATOC PET targets somatostatin receptors (SSTR s) and is
well established for the detection of SSTR‐expressing tumors, such as gastrointestinal …

Pituitary uptake of [111In-DTPA]-octreotide is highly variable, and no formal methods for
quantification have been described. Conflicting results have therefore been published as to …